Laboratorio Reig Jofre, S.A. (BME:RJF)

Market Cap	241.71M
Revenue (ttm)	340.41M
Net Income (ttm)	10.87M
Shares Out	81.38M
EPS (ttm)	n/a
PE Ratio	22.25
Forward PE	16.50
Dividend	0.05 (1.65%)
Ex-Dividend Date	May 15, 2025

Volume	2,855
Average Volume	31,202
Open	2.970
Previous Close	2.970
Day's Range	2.970 - 3.000
52-Week Range	2.460 - 3.400
Beta	0.82
RSI	39.07
Earnings Date	Jul 25, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,331
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 338.90 million, an increase of 6.59% compared to the previous year's 317.95 million. Earnings were 10.47 million, an increase of 11.27%.